Ventyx Biosciences Inc.

NASDAQ: VTYX · Real-Time Price · USD
2.85
-0.15 (-5.00%)
At close: Aug 15, 2025, 3:59 PM
2.88
1.18%
After-hours: Aug 15, 2025, 06:58 PM EDT

Ventyx Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.45M 1.45M 1.45M 1.08M 1.08M 1.08M 1.08M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
988K 981K 1.03M 1.44M 1.39M 1.22M 941K 688K 550K 514K 470K 336K 218K 119K 30K 14K 5K 1K
Gross Profit
-264K -257K -309K -360K -316K -139K 135K -688K -550K -514K -470K -336K -218K -119K -30K -14K -5K -1K
Operating Income
-130.4M -136.78M -148.45M -166.38M -185.78M -207.21M -207.99M -196.22M -169.69M -132.94M -113.14M -92.39M -73.76M -64.55M -67.15M -50.76M -40.21M -30.71M
Interest Income
11.44M 12.86M 13.42M 13.98M 14.56M 14.68M 15.07M 14.64M 11.72M 8.16M 4.67M 1.48M 474K 132K n/a n/a n/a 55.5K
Pretax Income
-119.03M -123.99M -135.12M -152.52M -171.3M -192.6M -192.96M -181.42M -157.86M -124.63M -108.43M -90.98M -73.29M -68.83M -83.75M -82.68M -77.06M -63.66M
Net Income
-119.03M -123.99M -135.12M -152.52M -171.3M -192.6M -189.34M -177.65M -153.13M -119.9M -107.3M -90.01M -73.28M -68.82M -83.75M -82.68M -77.06M -63.66M
Selling & General & Admin
29.79M 30.31M 30.72M 30.55M 30.83M 31.82M 31.32M 32.29M 30.04M 27.18M 25.4M 21.01M 17.3M 13.26M 8.67M 4.8M 2.8M 1.28M
Research & Development
100.61M 106.15M 117M 132.5M 151.62M 172.38M 174.07M 163.93M 139.65M 105.77M 87.74M 71.38M 56.45M 51.29M 58.48M 45.96M 37.41M 29.43M
Other Expenses
n/a n/a n/a 2.6M 2.6M 2.6M 2.6M 166K 166K 209K 225K 111K 124K 86K 71K 13K -1K -1K
Operating Expenses
130.4M 136.46M 147.73M 165.65M 185.05M 206.8M 207.99M 196.22M 169.69M 132.94M 113.14M 92.39M 73.76M 64.55M 67.15M 50.76M 40.21M 31.13M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 99K 252K 346K 346K
Selling & Marketing Expenses
n/a -316K -724K -1.63M -1.63M -1.31M -903K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
130.4M 136.78M 148.45M 166.38M 185.78M 207.21M 207.99M 196.22M 169.69M 132.94M 113.14M 92.39M 73.76M 64.55M 67.15M 50.76M 40.21M 31.13M
Income Tax Expense
n/a n/a 364.72K 364.72K 99.72K 99.72K -3.89M -4.04M -4.73M -4.73M -1.12M -915K 56K 56K 71K 13K n/a n/a
Shares Outstanding (Basic)
71.2M 71.13M 70.81M 70.67M 70.55M 61.83M 59.08M 58.88M 58.56M 57.64M 56.72M 51.67M 50.85M 50.59M 47.27M 47.27M 48.78M 48.78M
Shares Outstanding (Diluted)
71.2M 71.13M 70.81M 70.67M 70.55M 61.83M 59.08M 58.88M 58.56M 57.64M 56.72M 51.67M 50.85M 50.59M 47.27M 47.27M 48.78M 48.78M
EPS (Basic)
-1.68 -1.75 -1.98 -2.36 -2.78 -3.24 -3.23 -3.06 -2.71 -2.19 -2.03 -1.79 -1.49 -1.42 -1.74 -1.7 -1.77 -2.55
EPS (Diluted)
-1.68 -1.75 -1.98 -2.36 -2.78 -3.24 -3.23 -3.06 -2.71 -2.19 -2.03 -1.79 -1.49 -1.42 -1.74 -1.7 -1.77 -2.55
EBITDA
-116.09M -122.16M -133.77M -164.94M -184.38M -206M -207.05M -192.17M -165.78M -129.07M -109.31M -92M -73.47M -68.73M -83.62M -67.31M -61.6M -46.05M
EBIT
-114.73M -123.45M -135.12M -166.38M -185.78M -207.21M -207.99M -192.86M -166.33M -129.58M -109.78M -92.33M -73.69M -68.85M -83.65M -82.43M -76.72M -62.84M
Depreciation & Amortization
1.3M 1.3M 1.35M 1.44M 1.39M 1.22M 941K 688K 550K 514K 470K 336K 218K 119K 30K 1.45M 3.68M 5.36M